跳至主要内容
临床试验/NCT04181255
NCT04181255终止1 期

The Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy Following Deep Hypothermic Circulatory Arrest During Cardiac Surgery

University of Michigan1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2020年2月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
2
试验地点
1
主要终点
Number of days of mechanical ventilation

研究概览

简要总结

This clinical trial is being done to see if giving surfactant (Curosurf®) will decrease the number of days that infants will need a breathing tube, decrease the days in the critical care unit and decrease the number of days needed in the hospital. The primary hypothesis for this study is that there will be fewer days needed on mechanical ventilation and improved lung compliance and pulmonary gas exchange.

详细描述

This study will enroll infants undergoing cardiothoracic surgery requiring deep hypothermic circulatory arrest (DHCA) at the University of Michigan's C.S. Mott Children's Hospital. Patients that are eligible will be randomized to receive either one dose surfactant or the sham (air) arm after the surgical procedure. Patients will be monitored for an additional 30 days after the breathing tube is removed. It is possible that subjects may be discharged prior to the last assessment, therefore for subjects who have been discharged a member of the study team will contact the parent (s) or legal authorized representative by telephone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
1 Day 至 12 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Patients less than or equal to 12 weeks of age with hypoplastic left heart syndrome (HLHS) undergoing cardiothoracic surgical correction (Norwood) requiring DHCA.
  • Infants weighing 2500 grams or greater at the time of surgery.
  • Written informed consent from parent(s) or legally appointed representative (LAR).

排除标准

  • Patients who are less than 36 weeks Post Menstrual Age (PMA) at the time of surgical correction.
  • Underlying craniofacial, airway or lung anomalies which could compromise administration of surfactant.
  • Infants weighing less than 2500 grams at the time of the surgical correction.
  • Mechanical ventilation for> 7 days prior to surgical correction.

研究组 & 干预措施

Curosurf

Experimental

干预措施: Curosurf (Drug)

Sham (air)

Placebo Comparator

干预措施: Sham (Drug)

结局指标

主要结局

Number of days of mechanical ventilation

时间窗: Throughout hospitalization (approximate average 5 days)

This will be the number of days from intubation to the extubation date.

Number of days in the Pediatric Cardiothoracic Unit

时间窗: Approximately 11 days

From time of admission until transfer out of the unit.

Number of post-operative hospital days

时间窗: Up to 1 year

次要结局

  • Total number of patients requiring extracorporeal membrane oxygenation (ECMO) for pulmonary failure(Up to 1 year)
  • Total number of patients requiring thoracostomy tube placement for air leak not associated with standard post-operative management prior to extubation(Approximately 1 week)
  • Changes in positive end-expiratory pressures post intervention(Baseline to approximately 1 week)
  • Changes in peak inspiratory pressures post intervention(Baseline to approximately 1 week)
  • Changes in dynamic lung compliance post intervention(Baseline to approximately 1 week)
  • Changes in oxygen requirements post intervention(Baseline to approximately 1 week)
  • Changes in oxygenation index (OI) post intervention(Baseline to approximately 1 week)
  • Time to successful extubation readiness trials (ERT) post intervention(Approximately 1 week)
  • Total number of patients requiring high frequency ventilation (HFV) (High frequency oscillator ventilation or High frequency jet ventilation)(Up to 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven Donn, M.D.

Professor Emeritus of Pediatrics

University of Michigan

研究点 (1)

Loading locations...

相似试验